Interferon Tiloron Inductor Usage in Complex Therapy at Patients with Community-Acquired Pneumonia

The article presents the research findings concerning the importance of changes of the contents in blood serum of interferon gamma (INF-?), interferon alfa (INF-?), the tumor necrosis factor alfa (TNF-?), interleukin 4 (IL-4), interleukin8 (IL-8) and clinical parameters at patients with community-acquired pneumonia before the end of treatment (basic therapy and with immunomodulator tiloron). Tiloron positive influence on clinical manifestations and immunological parameters (profile of cytokines– IL-4, IL-8, INF-?, INF-? and INF-?) has been detected in patients with slightly complicated community-acquired pneumonia in 95 % of cases.